Powder: -20°C for 3 years | In solvent: -80°C for 1 year
α-Glucosidase-IN-23 is an orally active α-Glucosidase inhibitor. α-Glucosidase-IN-23 can decrease blood glucose by α-glucosidase inhibition (IC50= 4.48 μM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 329.00 | |
5 mg | In stock | $ 798.00 | |
10 mg | In stock | $ 1,090.00 | |
25 mg | In stock | $ 1,650.00 | |
50 mg | In stock | $ 2,230.00 | |
100 mg | In stock | $ 2,930.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 953.00 |
Description | α-Glucosidase-IN-23 is an orally active α-Glucosidase inhibitor. α-Glucosidase-IN-23 can decrease blood glucose by α-glucosidase inhibition (IC50= 4.48 μM). |
In vitro | α-Glucosidase-IN-23 (1 μM) exhibits significant anti-diabetes activity. α-Glucosidase-IN-23 decreases ROS levles in βcells and muscle cells. α-Glucosidase-IN-23 decreases blood glucose by α-glucosidase inhibition (IC50= 4.48 μM)[1]. |
In vivo | α- Glucosidase-IN-23 (oral; 0.2 mmol/kg/day) only inhibits α- Glucosidase in mice[1]. |
Molecular Weight | 373.4 |
Formula | C20H23NO6 |
CAS No. | 161187-57-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (66.95 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
α-Glucosidase-IN-23 161187-57-1 Metabolism Glucosidase alpha-Glucosidase-IN-23 a-Glucosidase-IN-23 αGlucosidaseIN23 inhibitor inhibit